Essange Reagents: an asset and an impact maker
Essange Reagents, acquired by Gilde Healthcare in '22, is ready to take the next step as international producer of hematology and immune reagents. An interesting investment, according to investment manager Ester Nafee: “They strive for a leading position in reagent development with the higher goal of helping patients.”